MENU
+Compare
CALC
Stock ticker: NASDAQ
AS OF
May 21 closing price
Price
$1.75
Change
-$0.11 (-5.91%)
Capitalization
24.45M

CALC CalciMedica Forecast, Technical & Fundamental Analysis

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more

CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CALC with price predictions
May 21, 2025

CALC's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for CALC moved into oversold territory on May 21, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for CALC crossed bullishly above the 50-day moving average on May 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CALC advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CALC moved out of overbought territory on May 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CALC as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CALC turned negative on May 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

CALC moved below its 50-day moving average on May 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CALC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CALC broke above its upper Bollinger Band on May 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CALC entered a downward trend on May 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.246) is normal, around the industry mean (16.453). P/E Ratio (0.297) is within average values for comparable stocks, (59.882). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.200). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (281.707).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CALC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CALC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CALC is expected to report earnings to rise 39.39% to -46 cents per share on May 10

CalciMedica CALC Stock Earnings Reports
Q1'23
Est.
$-0.46
Q4'24
Beat
by $0.65
Q4'22
Beat
by $0.08
Q3'22
Missed
by $0.05
Q2'22
Beat
by $0.02
The last earnings report on March 27 showed earnings per share of -33 cents, beating the estimate of -98 cents. With 34.46K shares outstanding, the current market capitalization sits at 24.45M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 Coast Boulevard South
Phone
+1 858 952-5500
Employees
14
Web
https://www.graybug.vision
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMXAX15.66N/A
N/A
Nationwide Mid Cap Market Idx A
GOGFX38.64N/A
N/A
Victory Sycamore Small Company Opp R
GLCUX33.18N/A
N/A
Goldman Sachs Large Cap Gr Insghts R6
RYRAX50.43N/A
N/A
Rydex Retailing H
RRGCX7.24N/A
N/A
DWS RREEF Global Real Estate Secc C

CALC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CALC has been loosely correlated with IMMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CALC jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
-5.91%
IMMP - CALC
38%
Loosely correlated
-3.48%
OBIO - CALC
33%
Poorly correlated
-7.12%
THAR - CALC
28%
Poorly correlated
-8.78%
ALDX - CALC
26%
Poorly correlated
-4.66%
VTYX - CALC
26%
Poorly correlated
-3.77%
More